DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,325,000 | -46.0% | 65,742 | 0.0% | 0.18% | -46.4% |
Q2 2021 | $2,453,000 | +45.9% | 65,742 | 0.0% | 0.34% | +35.2% |
Q1 2021 | $1,681,000 | +16.1% | 65,742 | 0.0% | 0.25% | +11.6% |
Q4 2020 | $1,448,000 | +37.6% | 65,742 | +12.5% | 0.22% | +37.4% |
Q3 2020 | $1,052,000 | -12.1% | 58,457 | +24.0% | 0.16% | -0.6% |
Q2 2020 | $1,197,000 | +38.2% | 47,143 | 0.0% | 0.16% | +18.0% |
Q1 2020 | $866,000 | -16.7% | 47,143 | 0.0% | 0.14% | +23.0% |
Q4 2019 | $1,039,000 | +283.4% | 47,143 | +150.0% | 0.11% | +253.1% |
Q3 2019 | $271,000 | -8.8% | 18,857 | 0.0% | 0.03% | -15.8% |
Q2 2019 | $297,000 | +7.6% | 18,857 | 0.0% | 0.04% | +8.6% |
Q1 2019 | $276,000 | +19.5% | 18,857 | 0.0% | 0.04% | 0.0% |
Q4 2018 | $231,000 | -19.8% | 18,857 | 0.0% | 0.04% | -14.6% |
Q3 2018 | $288,000 | +24.7% | 18,857 | 0.0% | 0.04% | +17.1% |
Q2 2018 | $231,000 | +28.3% | 18,857 | 0.0% | 0.04% | +20.7% |
Q1 2018 | $180,000 | – | 18,857 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |